$1.31
0.01[0.77%]
At close: Apr 15
$1.31
0[0.00%]
PreMarket: 6:39PM EDT
Enlivex Therapeutics
(NASDAQ:ENLV)Enlivex Therapeutics Stock (NASDAQ:ENLV), Quotes and News Summary
Enlivex Therapeutics Stock (NASDAQ: ENLV) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 264.000 / 156.876K |
| Day Range | - - - |
| 52 Wk Range | 1.150 - 4.590 |
| Market Cap | $24.364M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 24 |
| Short Interest | 1.36% |
| Days to Cover | 2.52 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focus...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Enlivex Therapeutics (ENLV) stock?
You can purchase shares of Enlivex Therapeutics (NASDAQ: ENLV) through any online brokerage.
Who are Enlivex Therapeutics's (ENLV) competitors?
There are no as such competitors for Enlivex Therapeutics.
What is the target price for Enlivex Therapeutics (ENLV) stock?
The latest price target for Enlivex Therapeutics (NASDAQ: ENLV) was reported by HC Wainwright & Co. on Friday, April 12, 2024. The analyst firm set a price target for 7.00 expecting ENLV to rise to within 12 months (a possible 434.35% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Enlivex Therapeutics (ENLV)?
The stock price for Enlivex Therapeutics (NASDAQ: ENLV) is $1.31 last updated April 15, 2024 at 6:39 PM EDT.
Does Enlivex Therapeutics (ENLV) pay a dividend?
There are no upcoming dividends for Enlivex Therapeutics.
When is Enlivex Therapeutics (NASDAQ:ENLV) reporting earnings?
Enlivex Therapeutics’s Q4 earnings are confirmed for Friday, March 29, 2024.
Is Enlivex Therapeutics (ENLV) going to split?
There is no upcoming split for Enlivex Therapeutics.
What sector and industry does Enlivex Therapeutics (ENLV) operate in?
Enlivex Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.